{"id":59775,"date":"2026-02-26T23:44:59","date_gmt":"2026-02-26T23:44:59","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/myeloproliferative-disorders-treatment-market-mordor\/"},"modified":"2026-11-06T20:21:18","modified_gmt":"2026-11-06T11:21:18","slug":"myeloproliferative-disorders-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/myeloproliferative-disorders-treatment-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/myeloproliferative-disorders-treatment-market_1664440390719_Picture_Like.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/myeloproliferative-disorders-treatment-market-size-image-1735459659061.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc2e0\uaddc \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uac15\ub825\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uc57d\ubb3c \uc874\uc7ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc57d\ubb3c \uad00\ub828 \ubd80\uc791\uc6a9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uac00\uce58 \uae30\uc900 \uc2dc\uc7a5 \uaddc\ubaa8 &#8211; \ubc31\ub9cc USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 MPD \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc9c4\uc131 \uc801\ud608\uad6c \uc99d\uac00\uc99d<\/li>\n<li class=\"toc-level-3\">5.1.2 \ubcf8\ud0dc\uc131 \ud608\uc18c\ud310 \uc99d\uac00\uc99d<\/li>\n<li class=\"toc-level-3\">5.1.3 \uace8\uc218\uc12c\uc720\uc99d<\/li>\n<li class=\"toc-level-3\">5.1.4 \uae30\ud0c0 MPD \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud654\ud559\uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.2.2 \uba74\uc5ed\uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc904\uae30\uc138\ud3ec \uc774\uc2dd<\/li>\n<li class=\"toc-level-3\">5.2.4 \uae30\ud0c0 \uce58\ub8cc\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.3.3 \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uae30\uc5c5 \ud504\ub85c\ud544\n<ul>\n<li class=\"toc-level-3\">6.1.1 \uc560\ube0c\ube44<\/li>\n<li class=\"toc-level-3\">6.1.2 \ube0c\ub9ac\uc2a4\ud1a8-\ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045<\/li>\n<li class=\"toc-level-3\">6.1.3 \uc778\uc0ac\uc774\ud2b8 \ucf54\ud37c\ub808\uc774\uc158<\/li>\n<li class=\"toc-level-3\">6.1.4 \ube44\uc544\ud2b8\ub9ac\uc2a4 (\ub9c8\uc77c\ub780 N.V.)<\/li>\n<li class=\"toc-level-3\">6.1.5 \ub178\ubc14\ud2f0\uc2a4 AG<\/li>\n<li class=\"toc-level-3\">6.1.6 \ud654\uc774\uc790<\/li>\n<li class=\"toc-level-3\">6.1.7 \ud14c\ubc14 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4<\/li>\n<li class=\"toc-level-3\">6.1.8 \ub2e4\ucf00\ub2e4 \uc81c\uc57d \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\ubaa9\ub85d\uc740 \uc644\uc804\ud558\uc9c0 \uc54a\uc74c<\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<\/p>\n<div style=\"font-family:regular_semibold\">\uc774\uc6a9 \uac00\ub2a5 \uc5ec\ubd80\uc5d0 \ub530\ub77c \ub2ec\ub77c\uc9c8 \uc218 \uc788\uc74c<\/div>\n<div style=\"font-family:regular_semibold\">\uacbd\uc7c1 \ud658\uacbd\uc740 \ub2e4\uc74c\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4: \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \uadf8\ub9ac\uace0 \ucd5c\uadfc \uac1c\ubc1c<\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5: \uaddc\ubaa8, \uc810\uc720\uc728 \ubc0f \uc0b0\uc5c5 \ubd84\uc11d \uac1c\uc694<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd<br \/>\n\uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(Myeloproliferative Disorder, MPD) \uce58\ub8cc \uc2dc\uc7a5\uc740 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 4.9%\ub97c \uae30\ub85d\ud558\uba70 \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 2019\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc2dc\uc7a5 \uaddc\ubaa8, \uc810\uc720\uc728 \ubc0f \uc0b0\uc5c5 \ubd84\uc11d\uc744 \ub2e4\ub8e8\uba70, 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \ub370\uc774\ud130\uc640 2019\ub144\ubd80\ud130 2023\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \ub370\uc774\ud130\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uc8fc\uc694 \ud1b5\uacc4<br \/>\n\uc774 \uc2dc\uc7a5\uc740 \ub2e4\uc74c\uacfc \uac19\uc774 \uc138\ubd84\ud654\ub429\ub2c8\ub2e4:<br \/>\n*   MPD \uc720\ud615\ubcc4: \uc9c4\uc131 \uc801\ud608\uad6c \uc99d\uac00\uc99d(Polycythaemia Vera), \ubcf8\ud0dc\uc131 \ud608\uc18c\ud310 \uc99d\uac00\uc99d(Essential Thrombocythemia), \uace8\uc218\uc12c\uc720\uc99d(Myelofibrosis), \uae30\ud0c0 MPD \uc720\ud615.<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \ud654\ud559\uc694\ubc95(Chemotherapy), \uba74\uc5ed\uc694\ubc95(Immunotherapy), \uc904\uae30\uc138\ud3ec \uc774\uc2dd(Stem Cell Transplantation), \uae30\ud0c0 \uce58\ub8cc\ubc95.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0(Hospitals), \uc804\ubb38 \ud074\ub9ac\ub2c9(Specialty Clinics), \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \uacb0\uacfc, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \uc608\uce21\ub418\uba70, \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \ub0ae\uc740 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>3. COVID-19 \ud32c\ub370\ubbf9\uc758 \uc601\ud5a5<br \/>\nCOVID-19 \ud32c\ub370\ubbf9\uc740 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4. \ud32c\ub370\ubbf9\uc73c\ub85c \uc778\ud574 \ub9cc\uc131 \uace8\uc218\uc99d\uc2dd\uc131 \uc2e0\uc0dd\ubb3c(Myeloproliferative Neoplasm, MPN) \ubc0f \uad00\ub828 \uc9c8\ud658\uc758 \uc0ac\ub840\uac00 \uc99d\uac00\ud588\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2021\ub144 9\uc6d4 \ubbf8\uad6d \ud608\uc561\ud559\ud68c(American Society of Hematology) \ubc1c\ud45c\uc5d0 \ub530\ub974\uba74, \uc911\uac04 2\ub2e8\uacc4 \ub610\ub294 \uace0\uc704\ud5d8 \uace8\uc218\uc12c\uc720\uc99d \ud658\uc790\ub294 COVID-19\uc5d0 \uac10\uc5fc\ub420 \uacbd\uc6b0 \ub354 \ub192\uc740 \uc704\ud5d8\uc5d0 \ucc98\ud560 \uc218 \uc788\uc73c\uba70, COVID-19 \ud658\uc790, \ud2b9\ud788 \uc9c8\ubcd1\uc758 \uc9c4\ud589 \ub2e8\uacc4\uc5d0 \uc788\ub294 \ud658\uc790\ub4e4\uc5d0\uac8c\uc11c \ud608\uc804\uc0c9\uc804\uc99d(Thromboembolic, TE) \ud569\ubcd1\uc99d\uc774 \uc99d\uac00\ud558\ub294 \uacbd\ud5a5\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uace8\uc218\uc99d\uc2dd\uc131 \uc2e0\uc0dd\ubb3c \ud658\uc790\uc758 \uacbd\uc6b0, \uae30\uc874\uc5d0 \ud608\uc804 \ubc0f\/\ub610\ub294 \ucd9c\ud608 \ud569\ubcd1\uc99d\uacfc \uad00\ub828\ub41c \uc9c8\ubcd1 \uc704\ud5d8\uc774 \uc788\uc5c8\uc73c\ubbc0\ub85c COVID-19\ub85c \uc778\ud55c \ud608\uc804\uc0c9\uc804\uc99d \ud569\ubcd1\uc99d\uc758 \uc99d\uac00\ub294 \uc2ec\uac01\ud55c \uc6b0\ub824 \uc0ac\ud56d\uc73c\ub85c \ubd80\uc0c1\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(MPD) \uc0ac\ub840\uc758 \uc99d\uac00\ub294 \uce58\ub8cc\uc728 \uc99d\uac00\ub85c \uc774\uc5b4\uc838 \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc2e0\uaddc \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud22c\uc790 \uc99d\uac00\uc640 \uac15\ub825\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uc57d\ubb3c\uc758 \uc874\uc7ac\uac00 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2021\ub144 12\uc6d4 \uc720\ub7fd \uc704\uc6d0\ud68c(European Commission) \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uc720\ub7fd \uc5f0\ud569 \uae30\ubc18 \uae30\uc5c5\ub4e4\uc740 \uac74\uac15 \ubd84\uc57c R&#038;D \ud22c\uc790\ub97c \ucd5c\ub300 10.3%\uae4c\uc9c0 \ub298\ub838\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ubbf8\uad6d\uacfc \uc911\uad6d \uae30\uc5c5\ub4e4\uc740 \uc804\uccb4 R&#038;D \ud22c\uc790\ub97c \uac01\uac01 9.1%\uc640 18.1% \uc99d\uac00\uc2dc\ucf30\uc73c\uba70, \ud2b9\ud788 \ucf54\ub85c\ub098\ubc14\uc774\ub7ec\uc2a4 \uc704\uae30 \ub3d9\uc548 \ud5ec\uc2a4\ucf00\uc5b4 \ubd80\ubb38 R&#038;D \ube44\uc911\uc744 \ubbf8\uad6d\uc740 17.9%, \uc911\uad6d\uc740 30.7%\uae4c\uc9c0 \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c R&#038;D \ud22c\uc790\ub294 \uc9c8\ubcd1 \uad00\ub828 \uc5f0\uad6c, \uc784\uc0c1 \uc2dc\ud5d8 \ubc0f \uc9c8\ud658 \ud1f4\uce58\ub97c \uc704\ud55c \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n\ub610\ud55c, \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658 \uc0ac\ub840\uc758 \uc99d\uac00\ub3c4 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825 \uc911 \ud558\ub098\uc785\ub2c8\ub2e4. 2022\ub144 5\uc6d4\uc5d0 \ubc1c\ud45c\ub41c &#8220;\uace8\uc218\uc99d\uc2dd\uc131 \uc2e0\uc0dd\ubb3c&#8221; \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \uace8\uc218\uc99d\uc2dd\uc131 \uc2e0\uc0dd\ubb3c\uc740 \ub0a8\uc131\uc5d0\uac8c\uc11c \ub354 \ud754\ud558\uac8c \ubc1c\uc0dd\ud558\uba70, \ub0a8\uc131\uc758 \ubc1c\ubcd1\ub960\uc740 10\ub9cc \uba85\ub2f9 \uc57d 2.4\uac74\uc778 \ubc18\uba74 \uc5ec\uc131\uc740 10\ub9cc \uba85\ub2f9 1.4\uac74\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc9c8\ud658 \uc0ac\ub840 \uc99d\uac00\ub294 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc0c1\ub2f9\ud55c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc774\ub04c \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>5. \uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778<br \/>\n\uadf8\ub7ec\ub098 \uc57d\ubb3c\uacfc \uad00\ub828\ub41c \ubd80\uc791\uc6a9\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud560 \uac00\ub2a5\uc131\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>*   \uace8\uc218\uc12c\uc720\uc99d(Myelofibrosis) \ubd80\ubb38\uc758 \uc131\uc7a5:<br \/>\n    \uace8\uc218\uc12c\uc720\uc99d \ubd80\ubb38\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uace8\uc218\uc12c\uc720\uc99d\uc740 \uace8\uc218\uac00 \ud749\ud130 \uc870\uc9c1\uc73c\ub85c \ub300\uccb4\ub418\uc5b4 \uac74\uac15\ud55c \ud608\uc561 \uc138\ud3ec\ub97c \ub9cc\ub4e4 \uc218 \uc5c6\ub294 \ud76c\uadc0 \uace8\uc218\uc554\uc758 \uc77c\uc885\uc73c\ub85c, \ub9cc\uc131 \ubc31\ud608\ubcd1\uc758 \ud55c \uc720\ud615\uc774\uc790 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658\uc5d0 \uc18d\ud569\ub2c8\ub2e4. \uc5f0\uad6c \ud65c\ub3d9 \uc99d\uac00\uc640 \uace8\uc218\uc12c\uc720\uc99d \ubc1c\ubcd1\ub960 \uc0c1\uc2b9\uc774 \uc774 \ubd80\ubb38\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4. 2021\ub144 10\uc6d4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \ubbf8\uad6d \ub0b4 \uc6d0\ubc1c\uc131 \uace8\uc218\uc12c\uc720\uc99d\uc758 \ucd94\uc815 \ubc1c\ubcd1\ub960\uc740 10\ub9cc \uc778\ub144(person-years)\ub2f9 \uc57d 0.3\uac74\uc785\ub2c8\ub2e4. 2020\ub144 6\uc6d4 \ubc31\ud608\ubcd1 \uc7ac\ub2e8(Leukaemia Foundation) \uae30\uc0ac\uc5d0 \ub530\ub974\uba74, \uc6d0\ubc1c\uc131 \uace8\uc218\uc12c\uc720\uc99d\uc740 \ud76c\uadc0 \ub9cc\uc131 \uc9c8\ud658\uc73c\ub85c \uc778\uad6c 10\ub9cc \uba85\ub2f9 \uc57d 1\uba85\uc774 \uc9c4\ub2e8\ubc1b\uc73c\uba70, \uc8fc\ub85c 60\uc138\uc5d0\uc11c 70\uc138 \uc0ac\uc774\uc5d0 \uc9c4\ub2e8\ub429\ub2c8\ub2e4. \ub610\ud55c, \uace8\uc218\uc12c\uc720\uc99d \uce58\ub8cc\ub97c \uc704\ud55c \uc9c0\uc18d\uc801\uc778 \uc2e0\uc57d \ucd9c\uc2dc\ub3c4 \ubd80\ubb38 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2022\ub144 5\uc6d4 Active Biotech AB\ub294 \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc774 \ud0c0\uc2a4\ud034\ub2c8\ubaa8\ub4dc(tasquinimod)\ub97c \uace8\uc218\uc12c\uc720\uc99d \uce58\ub8cc\ub97c \uc704\ud55c \ud76c\uadc0\uc758\uc57d\ud488\uc73c\ub85c \uc9c0\uc815\ud588\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ubd81\ubbf8 \uc9c0\uc5ed\uc758 \uc2dc\uc7a5 \uc9c0\ubc30\ub825:<br \/>\n    \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(MPD) \uce58\ub8cc \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658 \uc0ac\ub840 \uc99d\uac00, \uc5f0\uad6c \uac1c\ubc1c \ud22c\uc790 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc774 \uc9c0\uc5ed\uc5d0\uc11c \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658\uc758 \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \ud65c\ub3d9 \uc99d\uac00\uc640 \uac19\uc740 \uc694\uc778\ub4e4 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2020\ub144 9\uc6d4 \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045 \uce90\ub098\ub2e4(BMS)\ub294 \uce90\ub098\ub2e4 \ubcf4\uac74\ubd80(Health Canada)\uac00 \uc911\uac04-2\ub2e8\uacc4 \ub610\ub294 \uace0\uc704\ud5d8 \uc6d0\ubc1c\uc131 \uace8\uc218\uc12c\uc720\uc99d, \uc9c4\uc131 \uc801\ud608\uad6c \uc99d\uac00\uc99d \ud6c4 \uace8\uc218\uc12c\uc720\uc99d \ub610\ub294 \ubcf8\ud0dc\uc131 \ud608\uc18c\ud310 \uc99d\uac00\uc99d \ud6c4 \uace8\uc218\uc12c\uc720\uc99d\uc73c\ub85c \uc778\ud55c \ube44\uc7a5 \ube44\ub300 \ubc0f \uad00\ub828 \uc99d\uc0c1\uc744 \uce58\ub8cc\ud558\ub294 \uc131\uc778\uc6a9 \uc2e0\uaddc 1\uc77c 1\ud68c \uacbd\uad6c \uc57d\ubb3c\uc778 \uc778\ub808\ube45(INREBIC, fedratinib)\uc744 \uc2b9\uc778\ud588\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n    \uc8fc\uc694 \uc81c\ud488 \ucd9c\uc2dc, \uc2dc\uc7a5 \ucc38\uc5ec\uc790 \ub610\ub294 \uc81c\uc870\uc5c5\uccb4\uc758 \ub192\uc740 \uc9d1\uc911\ub3c4, \uc8fc\uc694 \uae30\uc5c5 \uac04\uc758 \uc778\uc218 \ubc0f \ud30c\ud2b8\ub108\uc2ed, \ubbf8\uad6d \ub0b4 \uc8fc\uc694 \uae30\uc5c5\uc758 R&#038;D \ud22c\uc790 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc5f0\uad6c \ud65c\ub3d9 \uc99d\uac00\ub294 \uc774 \uad6d\uac00\uc758 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(MPD) \uce58\ub8cc \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc774\ub044\ub294 \uc694\uc778\ub4e4\uc785\ub2c8\ub2e4. 2021\ub144 4\uc6d4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \ud604\uc7ac \ube44-\uc57c\ub204\uc2a4 \ud0a4\ub098\uc81c(JAK) \uc5b5\uc81c\uc81c \uae30\ubc18 \uce58\ub8cc\ubc95\uc774 \uc804\uc784\uc0c1 \ubc0f \uc784\uc0c1 \ud658\uacbd\uc5d0\uc11c \ud0d0\uc0c9\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. JAK \uc5b5\uc81c\uc81c\uac00 \uace8\uc218\uc12c\uc720\uc99d \uce58\ub8cc\uc5d0 \uc2b9\uc778\ub418\uc5c8\uc74c\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc9c8\ubcd1 \uc9c4\ud589\uc5d0 \ud070 \uc601\ud5a5\uc744 \ubbf8\uce58\uc9c0 \uc54a\uc73c\uba70, \ub9ce\uc740 \ud658\uc790\uac00 \ub3d9\ubc18\ub418\ub294 \ud608\uad6c\uac10\uc18c\uc99d\uc73c\ub85c \uc778\ud574 \ubd80\uc801\ud569\ud558\uace0, JAK \uc5b5\uc81c\uc81c\uc5d0 \ubd88\uc751\uc131\uc778 \ud658\uc790\ub4e4\uc758 \uc0dd\uc874\uc728\ub3c4 \uc88b\uc9c0 \uc54a\uc544, \ub354 \ub192\uc740 \ud6a8\ub2a5\uc73c\ub85c \uc9c8\ud658\uc744 \ud1f4\uce58\ud558\uae30 \uc704\ud55c \uc5f0\uad6c\uac00 \ud65c\ubc1c\ud788 \uc9c4\ud589\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(MPD) \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uadf8\ub9ac\uace0 \uc9c0\uc5ed\uc801\uc73c\ub85c \ud65c\ub3d9\ud558\ub294 \uc18c\uc218\uc758 \uc8fc\uc694 \uae30\uc5c5\ub4e4\ub85c \uc778\ud574 \ud1b5\ud569\ub41c(consolidated) \ud2b9\uc131\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc8fc\uc694 \uacbd\uc7c1 \uae30\uc5c5\uc73c\ub85c\ub294 AbbVie, Bristol-Myers Squibb, Incyte Corporation, Mylan NV, Novartis AG, Pfizer, Takeda Pharmaceutical Company Limited, Viatris (Mylan N.V.) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>8. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<br \/>\n*   2022\ub144 2\uc6d4: \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc740 JAK2, IRAK1 \ubc0f CSF1R\uc5d0 \ud2b9\uc774\uc131\uc744 \uac16\ub294 \uacbd\uad6c \ud0a4\ub098\uc81c \uc5b5\uc81c\uc81c\uc778 \ud30c\ud06c\ub9ac\ud2f0\ub2d9(pacritinib, Vonjo)\uc744 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc911\uac04 \ub610\ub294 \uace0\uc704\ud5d8 \uc6d0\ubc1c\uc131 \ub610\ub294 \uc774\ucc28\uc131 \uace8\uc218\uc12c\uc720\uc99d \uce58\ub8cc\uc5d0 \uc0ac\uc6a9\ub420 \uc608\uc815\uc774\uba70, \ud2b9\ud788 \uc2ec\uac01\ud55c \ud608\uc18c\ud310 \uac10\uc18c\uc99d(thrombocytopenia) \ud658\uc790\ub97c \uc704\ud55c \ucd5c\ucd08\uc758 \uce58\ub8cc\uc81c\uc785\ub2c8\ub2e4.<br \/>\n*   2021\ub144 12\uc6d4: \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc740 \uc9c4\uc131 \uc801\ud608\uad6c \uc99d\uac00\uc99d \uce58\ub8cc\ub97c \uc704\ud574 \ub85c\ud398\uae34\ud130\ud398\ub860 \uc54c\ud30c-2b(ropeginterferon \u03b1-2b, Besremi)\ub97c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uace8\uc218\uc99d\uc2dd\uc131 \uc9c8\ud658(Myeloproliferative Disorders, MPD) \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. MPD\ub294 \uc801\ud608\uad6c, \ubc31\ud608\uad6c \ubc0f \ud608\uc18c\ud310 \uc0dd\uc131\uc744 \uc790\uadf9\ud558\ub294 JAK2 \ud6a8\uc18c\uc758 \uc9c0\uc18d\uc801\uc778 \ud65c\uc131\ud654\ub97c \uc720\ubc1c\ud558\ub294 \uacf5\ud1b5\uc801\uc778 \ub3cc\uc5f0\ubcc0\uc774\ub97c \uacf5\uc720\ud558\ub294 \uc870\ud608\ubaa8\uc138\ud3ec \uc9c8\ud658\uc758 \ub3c5\ud2b9\ud55c \uadf8\ub8f9\uc785\ub2c8\ub2e4. \uc8fc\uc694 \uc720\ud615\uc73c\ub85c\ub294 \uace8\uc218\uc12c\uc720\uc99d(Myelofibrosis, MF), \uc9c4\uc131\uc801\ud608\uad6c\uc99d\uac00\uc99d(Polycythemia Vera, PV), \ubcf8\ud0dc\uc131\ud608\uc18c\ud310\uc99d\uac00\uc99d(Essential Thrombocythemia, ET) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \ubc94\uc704<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 MPD \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc5f0\uad6c \uac00\uc815, \uc2dc\uc7a5 \uc815\uc758 \ubc0f \uc5f0\uad6c \ubc94\uc704\ub97c \uba85\ud655\ud788 \ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8\ub294 USD \ubc31\ub9cc \ub2e8\uc704\ub85c \uc81c\uc2dc\ub418\uba70, 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc5ed\ud559<br \/>\n*   \uc2dc\uc7a5 \ub3d9\uc778: \uc2e0\uaddc \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c \ud22c\uc790 \uc99d\uac00\uc640 \uac15\ub825\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uc57d\ubb3c\uc758 \uc874\uc7ac\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4.<br \/>\n*   \uc2dc\uc7a5 \uc81c\uc57d: \uc57d\ubb3c \uad00\ub828 \ubd80\uc791\uc6a9\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<br \/>\n*   Porter\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d: \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uacbd\uc7c1 \ud658\uacbd\uc744 \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\nMPD \uce58\ub8cc \uc2dc\uc7a5\uc740 \ub2e4\uc74c\uacfc \uac19\uc740 \uae30\uc900\uc73c\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   MPD \uc720\ud615\ubcc4: \uc9c4\uc131\uc801\ud608\uad6c\uc99d\uac00\uc99d, \ubcf8\ud0dc\uc131\ud608\uc18c\ud310\uc99d\uac00\uc99d, \uace8\uc218\uc12c\uc720\uc99d, \uae30\ud0c0 MPD \uc720\ud615.<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \ud654\ud559\uc694\ubc95, \uba74\uc5ed\uc694\ubc95, \uc904\uae30\uc138\ud3ec \uc774\uc2dd, \uae30\ud0c0 \uce58\ub8cc\ubc95.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ubc0f \uae30\ud0c0 \uc720\ub7fd), \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ubc0f \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC, \ub0a8\uc544\ud504\ub9ac\uce74 \ubc0f \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098 \ubc0f \uae30\ud0c0 \ub0a8\ubbf8). \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \uc8fc\uc694 \uc9c0\uc5ed\uc5d0 \uac78\uccd0 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ub3d9\ud5a5\uc744 \ucd94\uc815\ud569\ub2c8\ub2e4.<\/p>\n<p>4. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\uc73c\ub85c\ub294 AbbVie, Bristol-Myers Squibb, Incyte Corporation, Viatris (Mylan N.V.), Novartis AG, Pfizer, Teva Pharmaceuticals, Takeda Pharmaceutical Company Limited \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd \uc139\uc158\uc5d0\uc11c\ub294 \uac01 \uae30\uc5c5\uc758 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>5. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc758 \uc7a0\uc7ac\uc801 \uae30\ud68c\uc640 \ubbf8\ub798 \ub3d9\ud5a5\uc5d0 \ub300\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>6. \uc8fc\uc694 \uc2dc\uc7a5 \ud1b5\ucc30<br \/>\n*   \uc2dc\uc7a5 \uc131\uc7a5\ub960: \uae00\ub85c\ubc8c MPD \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 4.9%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc8fc\uc694 \uae30\uc5c5: Novartis AG, Bristol-Myers Squibb, Incyte Corporation, Takeda Pharmaceutical Company Limited, Viatris (Mylan N.V.)\uac00 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\uc785\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728: 2025\ub144 \uae30\uc900, \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uae00\ub85c\ubc8c MPD \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 MPD \uce58\ub8cc \uc2dc\uc7a5\uc758 \ud604\uc7ac \uc0c1\ud0dc, \ubbf8\ub798 \uc804\ub9dd \ubc0f \uc8fc\uc694 \ub3d9\uc778\uacfc \uc81c\uc57d \uc694\uc778\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uc5ec \uc774\ud574\uad00\uacc4\uc790\ub4e4\uc774 \uc815\ubcf4\uc5d0 \uc785\uac01\ud55c \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9b4 \uc218 \uc788\ub3c4\ub85d \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59775","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59775"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=59775"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59775\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=59775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=59775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=59775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}